Gamida Cell Top Management

GMDADelisted Stock  USD 1.40  0.09  6.04%   
Gamida Cell employs about 143 people. The company is managed by 12 executives with a total tenure of roughly 5 years, averaging almost 0.0 years of service per executive, having 11.92 employees per reported executive. Analysis of Gamida Cell's management performance can provide insight into the company performance.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Gamida Cell Management Team Effectiveness

The company has return on total asset (ROA) of (0.4147) % which means that it has lost $0.4147 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.0379) %, meaning that it created substantial loss on money invested by shareholders. Gamida Cell's management efficiency ratios could be used to measure how well Gamida Cell manages its routine affairs as well as how well it operates its assets and liabilities.

Gamida Cell Workforce Comparison

Gamida Cell is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,298. Gamida Cell holds roughly 143 in number of employees claiming about 4% of equities under Health Care industry.

Gamida Cell Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Gamida Cell insiders, such as employees or executives, is commonly permitted as long as it does not rely on Gamida Cell's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Gamida Cell insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Gamida Cell Notable Stakeholders

A Gamida Cell stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Gamida Cell often face trade-offs trying to please all of them. Gamida Cell's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Gamida Cell's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Abigail JenkinsCEO PresidentProfile
Mary MBAPrincipal CFOProfile
Penny BushellChief OfficerProfile
Tracey LodieChief Scientific OfficerProfile
Joshua PattersonGeneral OfficerProfile
Paul NeeVP MarketingProfile
Vladimir MelnikovSenior ManufacturingProfile
Linda StamlerVice ManagementProfile
Heather DiVecchiaChief StaffProfile
Naftali CPASenior OperationsProfile
RPh MBAChief OfficerProfile
Ronit MDChief OfficerProfile

About Gamida Cell Management Performance

The success or failure of an entity such as Gamida Cell often depends on how effective the management is. Gamida Cell management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Gamida management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Gamida management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company was founded in 1998 and is headquartered in Jerusalem, Israel. Gamida Cell operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 166 people.
Please note, the presentation of Gamida Cell's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Gamida Cell's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Gamida Cell's management manipulating its earnings.

Gamida Cell Workforce Analysis

Traditionally, organizations such as Gamida Cell use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Gamida Cell within its industry.

Gamida Cell Manpower Efficiency

Return on Gamida Cell Manpower

Revenue Per Employee12.5K
Revenue Per Executive148.7K
Net Loss Per Employee440.5K
Net Loss Per Executive5.2M
Working Capital Per Employee205.2K
Working Capital Per Executive2.4M
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Consideration for investing in Gamida Stock

If you are still planning to invest in Gamida Cell check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gamida Cell's history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Money Managers
Screen money managers from public funds and ETFs managed around the world
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments